Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared on LinkedIn about his recent article, adding:
”Happy to share a new review article on thrombin generation testing I wrote and recently accepted by Clinics in Laboratory Medicine for a special edition.
The article describes a assay I am very passionate about which has the potential to give clinicians better information about patients’ global risk of bleeding or thrombosis.
The assay is not FDA cleared but available for research in the US and Canada.
It is being used in clinical settings internationally, though in limited volume.
Hopefully usage will increase over time especially if there’s a successful FDA submission at some point.
Thank you to the editors for inviting me to contribute.”
Title: Thrombin Generation Assay: Ready for Prime Time
Authors: Paul Riley
Read the Full Article on Clinics in Laboratory Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 29, 2026, 17:25Robert Brodsky: Ravulizumab Appears To Be Safe And Effective In Pregnancy
-
Apr 29, 2026, 16:53Chokri Ben Lamine: IV Iron Showdown – FCM vs Ferric Derisomaltose vs Iron Dextran
-
Apr 29, 2026, 16:46Deep Vein Thrombosis Risk in Jobs with Prolonged Sitting – NBCA
-
Apr 29, 2026, 16:41Vikramaditya Gangakar: Essential Pharmacy Facts You Should Know About Aspirin
-
Apr 29, 2026, 16:17W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
-
Apr 29, 2026, 16:12Mavis Agnes Kisakye: Concluding a Successful Entrepreneurs Training for Empowering Ptients’ Mothers
-
Apr 29, 2026, 15:48Kriti Batni: Happy to Share Current Use and Future Directions of Monoclonal Antibodies in Medicine Update 2026
-
Apr 29, 2026, 15:46Dima Shulkin: Comparing HALP and PIV for Mortality Prediction in ACS
-
Apr 29, 2026, 15:44Sonal Sonu: Securing First Prize in Research Oral Presentation at the CME